IP Library Granted Patent US 7,601,855
Granted Patent B2
US 7,601,855 · App. 11/230,726 · Granted Oct 13, 2009

Substituted chroman derivatives, medicaments and use in therapy

Assignee: Novogen Research Pty Ltd
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,601,855
App. No.
11/230,726
Granted
Oct 13, 2009
Kind
B2
Abstract

Novel substituted chroman derivatives and intermediate compounds, compositions containing same, methods for their preparation and uses thereof as therapeutic agents particularly as anti-cancer and chemotherapeutic selective agents are described.

Claims (43)

1. A compound of the general formula (I-b):

wherein:

R 1 is hydroxy, halo, C 1-6 alkoxy or C 1-6 alkyl;

the drawing and R 2 together represent a double bond or

the drawing represents a single bond and R 2 is hydrogen or hydroxy;

R 3 , R 4 , and R 5 , are independently hydrogen, hydroxy, NR 10 R 11 , C 1-6 alkoxy or C 1-6 alkyl;

R 6 is hydrogen, hydroxy, halo, C 1-6 alkoxy or C 1-6 alkyl;

R 7 is hydroxy or C 1-6 alkoxy;

R 8 and R 9 are independently hydrogen, hydroxy, halo, C 1-6 alkoxy or C 1-6 alkyl; and

R 10 and R 11 are independently hydrogen, C 1-6 alkyl or trialkyl silyl;

or a pharmaceutically acceptable salt thereof.

2. The compound of claim 1 , wherein:

R 1 is methyl, methoxy or halo;

R 3 is hydrogen, hydroxy, methoxy or amino;

R 4 and R 5 are hydrogen;

R 6 is hydrogen;

R 7 is hydroxy or methoxy; and

R 8 and R 9 are independently hydrogen, hydroxy, halo, methoxy or methyl;

or a pharmaceutically acceptable salt thereof.

3. The compound of claim 2 , wherein:

R 1 is methyl or bromo;

R 3 is methoxy and is in the 4″-position;

R 7 is hydroxy; and

R 8 is hydrogen and R 9 is hydrogen, hydroxy or methoxy, or

R 8 is hydroxy or methoxy and in the 3′-position and R 9 is hydrogen, or

R 8 and R 9 are both hydroxy or methoxy and R 8 is in the 3′-position;

or a pharmaceutically acceptable salt thereof.

4. The compound of claim 3 , wherein:

the drawing represents a single bond; and

R 2 is hydrogen and cis to the hydrogen at C-3.

5. The compound of claim 1 , wherein R 1 is methyl.

6. The compound of claim 1 , wherein R 3 is methoxy or hydroxy.

7. The compound of claim 6 , wherein R 7 is hydroxy or C 1-6 alkoxy.

8. The compound of claim 7 , wherein R 7 is hydroxy or methoxy.

9. The compound of claim 1 , wherein R 8 and R 9 independently are hydrogen, hydroxy or C 1-6 alkoxy.

10. The compound of claim 9 , wherein R 8 and R 9 independently are hydrogen, hydroxy or methoxy.

11. The compound of claim 10 , wherein one of R 8 or R 9 is hydroxy or methoxy and the other of R 8 or R 9 is hydrogen.

12. The compound of claim 1 , wherein said compound is compound 1.1, 2.1 or 3.1

or a salt thereof.

13. The compound of claim 1 , wherein said compound is selected from compound Nos. 1 to 9 and 42, as set forth below:

14. The compound of claim 1 , wherein said compound is selected from compound Nos. 16-24, as set forth below:

15. The compound of claim 1 , wherein said compound is selected from compound Nos. 32-40, as set forth below:

16. A composition which comprises one or more compounds of formula (I-b) of claim 1 , or a pharmaceutically acceptable salt thereof, in association with one or more pharmaceutical carriers, excipients, auxiliaries and/or diluents.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 27, 2024
From: MEI PHARMA, INC
To: AARDVARK THERAPEUTICS, INC.
Reel/Frame 069421/0953 →
CHANGE OF NAME Recorded Dec 5, 2014
From: MARSHALL EDWARDS, INC.
To: MEI PHARMA, INC.
Reel/Frame 034390/0267 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 8, 2012
From: NOVOGEN LIMITED; NOVOGEN RESEARCH PTY LIMITED
To: MARSHALL EDWARDS, INC.
Reel/Frame 028173/0113 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 10, 2006
From: HEATON, ANDREW; HUSBAND, ALAN
To: NOVOGEN RESEARCH PTY LTD.
Reel/Frame 017444/0374 →
Priority Claims (1)
WO PCT/AU2004/001619 · Nov 19, 2004 · international
Continuity (3)
Provisional Application 6067693400 · May 3, 2005
Provisional Application 6061130000 · Sep 21, 2004
Related Publication 20060074127A1 · Apr 6, 2006